Dariohealth announces additional commercial contracts for its digital therapeutic solutions

Two new b2b contracts reinforce dario's position as an emerging leader in multi-chronic digital health new york , may 19, 2022 /prnewswire/ -- dariohealth corp. (nasdaq: drio), a leader in the global digital therapeutics (dtx) market, announced today two new contracts to provide digital therapeutics solutions to a national employer and a provider, both of which are expected to begin enrolling members in the third quarter of 2022.   the texas-based, national employer selected dario to provide digital behavioral health support for employees in 17 states across the south and southeast united states; the east-coast provider group chose dario to provide its integrated metabolic solution for patients living with diabetes, high blood pressure and weight management support.
DRIO Ratings Summary
DRIO Quant Ranking